Treatment patterns and costs among patients with OAB treated with combination oral therapy, sacral nerve stimulation, percutaneous tibial nerve stimulation, or onabotulinumtoxinA in the United States.
Neurourol Urodyn
; 39(8): 2206-2222, 2020 11.
Article
in En
| MEDLINE
| ID: mdl-32827230
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Thiazoles
/
Electric Stimulation Therapy
/
Muscarinic Antagonists
/
Botulinum Toxins, Type A
/
Urinary Bladder, Overactive
/
Acetanilides
Type of study:
Health_economic_evaluation
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
America do norte
Language:
En
Journal:
Neurourol Urodyn
Year:
2020
Document type:
Article
Country of publication: